Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 11Urinary Bladder Neoplasms 6Carcinoma, Renal Cell 4Ovarian Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Pancreatic Neoplasms 2Melanoma 2Lung Neoplasms 2Colonic Neoplasms 2Urologic Neoplasms 1Urologic Diseases 1Ureteral Neoplasms 1Stroke 1Stomach Neoplasms 1Sarcoma 1Renal Insufficiency, Chronic 1Recurrence 1Rectal Neoplasms 1Pulmonary Disease, Chronic Obstructive 1Neoplasms 1Myelodysplastic Syndromes 1Localized Prostate Carcinoma 1Leukemia, Myeloid, Acute 1Kidney Failure, Chronic 1Hypogonadism 1Esophageal Neoplasms 1Disease Progression 1Diabetes Mellitus 1Coronary Artery Disease 1

Interventions

Alendronate 2testosterone undecanoate 1testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Testosterone 1Tamoxifen 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Orchiectomy 1Methyltestosterone 1Mental Status and Dementia Tests 1Castor Oil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hypogonadism × Practice Guidelines as Topic × Genitourinary × Clear all
NCT04731376 2026-05-26

Perioperative Testosterone Replacement Therapy for the Improvement of Post-Operative Outcomes in Patients With Low Testosterone

Emory University

Phase 1 Active not recruiting
56 enrolled
Genitourinary

Hypogonadism, Urologic Diseases, Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡